Texas State University Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2017
NCT03530774
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

M. Hunter Martaindale | Texas State University | Texas State University, San Marcos

Active Ingredients

Drugs in Other Trials (2)

egg white protein (1 trial)

maltodextrin (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 2